Business Context and Reporting Period
Company: Healthpeak Properties, Inc. (NYSE: DOC)
Filing Type: Form 8-K (Current Report)
Date of Report: December 9, 2024
Event: Entry into a Material Definitive Agreement involving the recasting of the Company's revolving credit facility and conforming amendments to term loan facilities.
Key Financial Metrics and Debt Structure
This filing details the terms of the Company's debt facilities rather than reporting period-specific operating results (revenue, profit, or cash flow).
- Revolving Facility Capacity: $3.0 billion senior unsecured revolving credit facility.
- Expansion Option: Capacity may be increased to up to $3.75 billion at the Company's option, subject to conditions.
- Maturity Date: January 19, 2029.
- Extension Option: The Company may extend the maturity for up to two additional six-month periods upon payment of a fee (0.0625% of aggregate commitments).
- Sublimits:
- Letters of Credit: Up to $100 million.
- Non-U.S. Dollar Loans: Up to $1.0 billion.
- Negotiated Rate Loans: Up to 50% of the facility.
- Interest Rates (as of Closing Date):
- SOFR Loans: 0.775% margin over SOFR.
- Base Rate Loans: 0.00% margin over Base Rate.
- Facility Fee: 0.15% per annum.
Material Changes Versus Prior Period
The Company entered into a Third Amended and Restated Credit Agreement, which amends and restates the Second Amended and Restated Credit Agreement dated September 20, 2021. Key changes include:
- Maturity Extension: The revolving facility maturity was extended to January 19, 2029.
- Conforming Amendments: The Company amended its existing term loan agreements (Healthpeak Term Loan and Physicians Realty Term Loan) to conform to the terms of the new revolving credit agreement. These amendments did not change the maturity, pricing, or amount of the outstanding term loans.
- Sustainability Link: A new provision allows for a sustainability-linked pricing component (adjustment of up to 0.01%) to be established within 12 months of closing.
Financial Covenants and Risks
The Amended Credit Agreements contain financial covenants tested on a quarterly basis. Failure to meet these could result in an event of default, requiring immediate repayment of outstanding amounts.
| Covenant Metric | Requirement |
|---|---|
| Enterprise Total Indebtedness to Enterprise Gross Asset Value | Maximum 60% |
| Enterprise Secured Debt to Enterprise Gross Asset Value | Maximum 40% |
| Enterprise Unsecured Debt to Enterprise Unencumbered Asset Value | Maximum 60% |
| Fixed Charge Coverage Ratio | Minimum 1.5 times |
| Consolidated Tangible Net Worth | Minimum $7.7 billion |
Risks and Contingencies: The filing notes that certain lenders and their affiliates engage in financial advisory and banking transactions with the Company. Additionally, the representations and warranties in the agreements are subject to contractual standards of materiality that may differ from investor perspectives.
Investor Verification Checklist
- Verify the Company's current compliance with the new financial covenants, specifically the $7.7 billion Consolidated Tangible Net Worth requirement.
- Review the full text of the Amended Revolving Credit Agreement (Exhibit 10.1) for specific definitions of "Enterprise Gross Asset Value" and "Enterprise Unencumbered Asset Value."
- Monitor the Company's debt ratings, as interest margins and facility fees are directly tied to these ratings.
- Confirm whether the Company intends to utilize the option to increase borrowing capacity to $3.75 billion or extend the maturity beyond 2029.